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   Anew deter皿ination of urinary trypsin inhibitor（UTI）was developed from casein－plate method．
We studied the relationship between the activity level of U ［’1 by the present method and the activity
level of urokinase （UK） by fibrin agar－plate method in various renal diseases．
   A sample of trypsin solution （Sigma， type II， 25 mM Ca2＋） was adsorbed to a filter paper （5．8
×5．8 mm）， and lyophilized to be fixed． Then 5 pl of urine was adsorbed to the above． lt was applied
on O．050／． casein－plate （10mM Ca2＋）， and incubated at 37eC． UTI activity level was determined
in lysis area of trypsin．
   The results were well correlated with those by the test－tube method already reported． ’rhe
procedure of the present method made it possible to test more simply compared with conventional
methods．
   The amount to inhibit 1 pg of trypsin was assigned to be one unit， as for UTI activity． As for
UK level in urine， UK was determined by fibrin agar－plate m：thod with commercial UK （Green
Cross Co． Ltd．） as the standard．
   The results are as follows：
   1． Normal human urine contains about 4．1 units of UTI and I I．1 IU of UK per ml． UTII
UK is approximately O．4．
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  2． The urine of the patients with renal disease showed high activity level in UTI and low in
UK．
  If UTI originated in blood and UK in kidney， it would be clinically useful to study the correlation
between those two for the clinical tests of various renal diseases．
  In the present study， it was confirmed that UT．1 purified by the following methods corresponded
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 Ampholine 8100（LKB Produkter AB）を用い，
carrier amph・lite（1％）はpH範囲3．5～10，精製







































Fig． 2． Casein－plate showing the inhibition of trypsin activity by UTI． Trypsin－paper
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Fig． 3． Standard curve of UTI activity． Tryp－
    sin－paper contains O．2 or O．8gg of
    trypsin． After the application of 5 ptl
    of several units of UTI， incubated for


































Table 1． UTI and UK activity in patients
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Fig． 4． Comparison of the UTI activity with
    tube method and new casein－plate
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Table 2． AfHnity chromatography of UTI on
     trypsin－sepharose． 5 rn1 of the arg．
     sepharose eluate （3，315 U， S．A．＝
     273．5U／mg protein）was apPlicd on
     a column （1．4×5cm） of the trypsin－
     sepharose at a flow rate of 1．8 ml per
     min at 40C． After the column was
     washed with 30 ml of O．05 M Tris－
     HCI buffer， containing O．2M NaCj
     （pH 7．8）， the UTI adsorbed was
     eluted with O．02 N HC1 containing







































8．15 H N．D．2．37 2．850 O．85    ’
N．D． ； not oetectea
   10 20 50 40 50
       Tube No． ［Eml／tube）
Fig． 5． Sephadex G－100 column chromatog．raphy
    of UT工． Column：2．5×40 cm，0．1M
    Phosphate buffer at pH 7．4 containing
    IM urea and I M NaC1． Apply：
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Fig． 6． lsoelectric focussing of UTI． 3．Omg of UTI was submitted to
    electrophoresis using a 110 ml column of carrier ampholytes of
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Fig． 7． Polyacrylamide gel electrophoresis of UTI． Highly purified UTI （ca． 200＃g






































































土岐・ほか：尿中トリプシンインヒ．ビ、タr・定量法           1059
2．0で，電気泳動的に血清prealbuminに一致し，か
つ熱安定性がきわめて．高い闇闇であることが判明した．
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